{"body":"<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>schizont<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Stage of the malaria parasite in host liver cells (hepatic schizont) or red blood cells (erythrocytic schizont) that is undergoing nuclear division by schizogony and, consequently, has more than one nucleus<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>screening<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Identification of groups at risk that may require further intervention, such as diagnostic testing, treatment or preventive services<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>selection pressure<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The force of an external agent that confers preferential survival; examples are the pressure of antimalarial medicines on malaria parasites and of insecticides on anopheline mosquitoes<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>sensitivity (of a test)<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Measured as the proportion of people with malaria infection (true positives) who have a positive result<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>serological assay<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Procedure used to measure antimalarial antibodies in serum<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>severe anaemia<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Haemoglobin concentration of &lt; 5 g\/100 mL (haematocrit &lt; 15%)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>severe falciparum malaria<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Acute falciparum malaria with signs of severe illness and\/or evidence of vital organ dysfunction<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>single-dose regimen<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Administration of a medicine as a single dose to achieve a therapeutic objective<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>slide positivity rate<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Proportion of blood smears found to be positive for <em>Plasmodium <\/em>among all blood smears examined<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>specificity (of a test)<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Measured as the proportion of people without malaria infection (true negatives) who have a negative result<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>sporozoite<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Motile stage of the malaria parasite that is inoculated by a feeding female anopheline mosquito and may cause infection<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>sporozoite rate<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Percentage of female <em>Anopheles <\/em>mosquitoes with sporozoites in the salivary glands<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>spray round<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Spraying of all sprayable structures in an area designated for coverage in an indoor residual spraying programme during a discrete period<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>sprayable<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">In the context of a malaria vector control programme, a unit (dwelling, house, room, shelter, structure, surface) suitable for spraying or required to be sprayed<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>spraying cycle<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Repetition of spraying operations at regular intervals, often designated in terms of the interval between repetitions, e.g., a 6-month spraying cycle when spraying is repeated after a 6-month interval<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>spraying frequency<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Number of regular applications of insecticide per house per year, usually by indoor residual spraying<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>spraying interval<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Time between successive applications of insecticide<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>spraying, focal<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Spray coverage by indoor residual spraying and\/or space spraying of houses or habitats in a limited geographical area<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>spraying, residual (IRS)<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Spraying the interior walls and ceilings of dwellings with a residual insecticide to kill or repel endophilic mosquito vectors of malaria<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>surveillance<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Continuous, systematic collection, analysis and interpretation of disease-specific data and use in planning, implementing and evaluating public health practice<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>synergist*<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A substance that does not itself have insecticidal properties, but that, when mixed and applied with insecticides of a particular class, considerably enhances their potency by inhibiting an enzyme that normally acts to detoxify the insecticide in the insect system<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>testing, malaria<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Use of a malaria diagnostic test to determine whether an individual has malaria infection<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>tolerance<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A response in a human or mosquito host to a given quantum of infection, toxicant or drug that is less than expected<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission intensity<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The frequency with which people living in an area are bitten by anopheline mosquitoes carrying human malaria sporozoites<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission season<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Period of the year during which most mosquito-borne transmission of malaria infection occurs<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission, re-establishment of<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Renewed presence of a measurable incidence of locally acquired malaria infection due to repeated cycles of mosquito-borne infections in an area in which transmission had been interrupted<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission, interruption of<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Cessation of mosquito-borne transmission of malaria in a geographical area as a result of the application of antimalarial measures<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission, perennial<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Transmission that occurs throughout the year with no great variation in intensity<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission, residual<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Persistence of malaria transmission following the implementation in time and space of a widely effective malaria programme<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission, seasonal<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Transmission that occurs only during some months of the year and is markedly reduced during other months<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission, stable<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Epidemiological type of malaria transmission characterized by a steady prevalence pattern, with little variation from one year to another except as the result of rapid scaling up of malaria interventions or exceptional environmental changes that affect transmission<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>transmission, unstable<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Epidemiological type of malaria transmission characterized by large variation in incidence patterns from one year to another<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>trap, mosquito<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Device designed for capturing mosquitoes with or without attractant components (light, CO2, living baits, suction)<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment failure<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Inability to clear malarial parasitaemia or prevent recrudescence after administration of an antimalarial medicine, regardless of whether clinical symptoms are resolved<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment, anti-relapse<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Antimalarial treatment designed to kill hypnozoites and thereby prevent relapses or late primary infections with <em>P. vivax<\/em> or <em>P. ovale<\/em><\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment, directly observed (DOT)<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Treatment administered under the direct observation of a health care worker<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment, first-line<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Treatment recommended in national treatment guidelines as the medicine of choice for treating malaria<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment, second-line<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Treatment used after failure of first-line treatment or in patients who are allergic to or unable to tolerate the first-line treatment<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment, presumptive<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Administration of an antimalarial drug or drugs to people with suspected malaria without testing or before the results of blood examinations are available<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment, preventive<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Intermittent administration of a full therapeutic course of an antimalarial either alone or in combination to prevent malarial illness by maintaining therapeutic drug levels in the blood throughout the period of greatest risk<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>treatment, radical<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Treatment to achieve complete cure. This applies only to vivax and ovale infections and consists of the use of medicines that destroy both blood and liver stages of the parasite.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>trophozoite<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The stage of development of malaria parasites growing within host red blood cells from the ring stage to just before nuclear division. Trophozoites contain malaria pigment that is visible by microscopy.<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>uncomplicated malaria<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Symptomatic malaria parasitaemia without signs of severity or evidence of vital organ dysfunction<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vector<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">In malaria, adult females of any mosquito species in which <em>Plasmodium <\/em>undergoes its sexual cycle (whereby the mosquito is the definitive host of the parasite) to the infective sporozoite stage (completion of extrinsic development), ready for transmission when a vertebrate host is bitten<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vector competence<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">For malaria, the ability of the mosquito to support completion of malaria parasite development after zygote formation and oocyst formation, development and release of sporozoites that migrate to salivary glands, allowing transmission of viable sporozoites when the infective female mosquito feeds again<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vector control<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Measures of any kind against malaria-transmitting mosquitoes, intended to limit their ability to transmit the disease<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vector susceptibility<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The degree to which a mosquito population is susceptible (i.e., not resistant) to insecticides<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vector, principal<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">The species of Anopheles mainly responsible for transmitting malaria in any particular circumstance<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vector, secondary or subsidiary<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Species of Anopheles thought to play a lesser role in transmission than the principal vector; capable of maintaining malaria transmission at a reduced level<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vectorial capacity<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">Number of new infections that the population of a given vector would induce per case per day at a given place and time, assuming that the human population is and remains fully susceptible to malaria<\/p>&#13;\n<\/div>&#13;\n&#13;\n<div class=\"glossary\">&#13;\n<p class=\"gltxt\"><strong>vigilance<\/strong><\/p>&#13;\n&#13;\n<p class=\"gldesc\">A function of the public health services for preventing reintroduction of malaria. Vigilance consists of close monitoring for any occurrence of malaria in receptive areas and application of the necessary measures to prevent re-establishment of transmission.<\/p>&#13;\n<\/div>&#13;\n","title":"Glossary: S - Z","nid":777,"vid":4342,"created":1627908344,"changed":1627908392,"field_content_type":{"tid":2,"name":"Content","class":"content"},"field_left_right_navigation":1,"field_operational_":[{"field_image":"","field_link":"","field_title":null}],"field_recommendations":1,"recommendation":"<p>All cases of suspected malaria should have a parasitological test (microscopy or Rapid diagnostic test (RDT)) to confirm the diagnosis.<br \/>\r\nBoth microscopy and RDTs should be supported by a quality assurance programme.<br \/>\r\n<font color=\"#4090CF\"><em>Good practice statement<\/em><\/font><\/p>\r\n","recommendation_title":"Rapid diagnostic test (RDT)","field_references":null}